| Trial ID: | L0993 |
| Source ID: | NCT00073710
|
| Associated Drug: |
Zemplar
|
| Title: |
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Secondary Hyperparathyroidism|Chronic Kidney Disease
|
| Interventions: |
DRUG: Zemplar|PROCEDURE: 42 Ca carbonate absorption via single tracer method|DRUG: Calcijex
|
| Outcome Measures: |
Primary: The mean within subject difference in calcium absorption rates between treatment regimens will be analyzed using ANOVA appropriate for a two-period cross-over trial. |
|
| Sponsor/Collaborators: |
Sponsor: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-09
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2006-08-02
|
| Locations: |
Creighton University, Omaha, Nebraska, 68131, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00073710
|
